Brainstorm Diagnostics
PrivateLast Round
Seed
Dec 14, 2021
Company Overview
Brainstorm Diagnostics is a biotechnology company developing a blood-based biomarker test for the early diagnosis and prognosis of traumatic brain injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brainstorm Diagnostics Comparables
Compare Brainstorm Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bioMérieux | 74% | |
| Abbott Laboratories | 72% | |
| Quanterix Corporation | 63% |
Brainstorm Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 14, 2021 |
Brainstorm Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Penn Center for Innovation | Seed |
Brainstorm Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Brainstorm Diagnostics's valuation, stock price, and market status.
Is Brainstorm Diagnostics a public or private company?
Brainstorm Diagnostics is a private company.
What is the current stock price of Brainstorm Diagnostics?
Brainstorm Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Brainstorm Diagnostics worth (valuation)?
Valuation information for Brainstorm Diagnostics is not publicly available.
Can I buy Brainstorm Diagnostics stock?
Brainstorm Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Brainstorm Diagnostics's last funding round?
Brainstorm Diagnostics's most recent funding round was Seed on December 14, 2021.
Who are the main investors in Brainstorm Diagnostics?
Key investors in Brainstorm Diagnostics include Penn Center for Innovation.
Will Brainstorm Diagnostics IPO soon?
No public IPO plans have been announced for Brainstorm Diagnostics.
How can I track Brainstorm Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Brainstorm Diagnostics's secondary market activity and sign up for updates.